je.st
news
Tag: financial
Microsoft Releases Financial Management Software For Startups
2017-06-19 12:07:10| Microsoft Watch from Mary Jo Foley
Microsoft has released its financial management software designed for early startups and home-based businesses. The product, Microsoft Office Accounting Express 2007, is desktop software that can be downloaded at no cost.
Tags: software
management
financial
microsoft
Dell Financial Services Buyout Could Be Boon to Dell Partners
2017-06-19 12:07:05| eWeek Finance
Dell said that by exercising its option to buy out CIT's 30 percent ownership, it opens the door to programs specifically tailored to channel partner needs.
Tags: services
financial
partners
dell
Consolidated Financial Statements for the twelve-month period ended March 31, 2017
2017-05-10 08:03:00| Tsubakimoto Chain Co.
Tsubakimoto Chain Co. Consolidated Financial Statements for the twelve-month period ended March 31, 2017
Tags: march
period
financial
ended
Consolidated Financial Statements for the nine-month period ended December 31, 2016
2017-02-07 07:00:00| Tsubakimoto Chain Co.
Tsubakimoto Chain Co. Consolidated Financial Statements for the nine-month period ended December 31, 2016
Tags: december
period
financial
ended
Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results
2017-02-02 12:45:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Fourth-Quarter 2016 Worldwide Sales Were $10.1 Billion, a Decrease of 1 Percent, Including a 1 Percent Negative Impact from Foreign Exchange; Full-Year 2016 Worldwide Sales Were $39.8 Billion, an Increase of 1 Percent, Including a 2 Percent Negative Impact from Foreign Exchange Fourth-Quarter 2016 GAAP EPS Was $0.42; Fourth-Quarter Non-GAAP EPS Was $0.89; Full-Year 2016 GAAP EPS Was $2.04; Full-Year Non-GAAP EPS Was $3.78 2017 Financial Outlook Expects Full-Year 2017 GAAP EPS to be Between $2.47 and $2.62; Expects Non-GAAP EPS to be Between $3.72 and $3.87, Including an Approximately 2 Percent Negative Impact from Foreign Exchange Anticipates Full-Year 2017 Worldwide Sales to be Between $38.6 Billion and $40.1 Billion, Including an Approximately 2 Percent Negative Impact from Foreign Exchange Advanced KEYTRUDA Development Program U.S. Food and Drug Administration (FDA) Approved KEYTRUDA for Previously Untreated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC) Whose Tumors Have High PD-L1 Expression (Tumor Proportion Score of 50 Percent or More) Without EGFR or ALK Genomic Tumor Aberrations FDA Granted Priority Review for Three Supplemental Biologics License Applications for KEYTRUDA KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of 2016. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE @Merck read more
Tags: results
financial
announces
merck
Sites : [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] next »